Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

110 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial.
Broekhuijsen K, van Baaren GJ, van Pampus MG, Ganzevoort W, Sikkema JM, Woiski MD, Oudijk MA, Bloemenkamp KW, Scheepers HC, Bremer HA, Rijnders RJ, van Loon AJ, Perquin DA, Sporken JM, Papatsonis DN, van Huizen ME, Vredevoogd CB, Brons JT, Kaplan M, van Kaam AH, Groen H, Porath MM, van den Berg PP, Mol BW, Franssen MT, Langenveld J; HYPITAT-II study group. Broekhuijsen K, et al. Among authors: porath mm. Lancet. 2015 Jun 20;385(9986):2492-501. doi: 10.1016/S0140-6736(14)61998-X. Epub 2015 Mar 25. Lancet. 2015. PMID: 25817374 Clinical Trial.
Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia between 34 and 37 weeks' gestation (HYPITAT-II): a multicentre, open-label randomised controlled trial.
Langenveld J, Broekhuijsen K, van Baaren GJ, van Pampus MG, van Kaam AH, Groen H, Porath M, Oudijk MA, Bloemenkamp KW, Groot CJ, van Beek E, van Huizen ME, Oosterbaan HP, Willekes C, Wijnen-Duvekot EJ, Franssen MT, Perquin DA, Sporken JM, Woiski MD, Bremer HA, Papatsonis DN, Brons JT, Kaplan M, Nij Bijvanck BW, Mol BW; HYPITAT-II study group. Langenveld J, et al. BMC Pregnancy Childbirth. 2011 Jul 7;11:50. doi: 10.1186/1471-2393-11-50. BMC Pregnancy Childbirth. 2011. PMID: 21736705 Free PMC article. Clinical Trial.
Foley catheter versus vaginal prostaglandin E2 gel for induction of labour at term (PROBAAT trial): an open-label, randomised controlled trial.
Jozwiak M, Oude Rengerink K, Benthem M, van Beek E, Dijksterhuis MG, de Graaf IM, van Huizen ME, Oudijk MA, Papatsonis DN, Perquin DA, Porath M, van der Post JA, Rijnders RJ, Scheepers HC, Spaanderman ME, van Pampus MG, de Leeuw JW, Mol BW, Bloemenkamp KW; PROBAAT Study Group. Jozwiak M, et al. Lancet. 2011 Dec 17;378(9809):2095-103. doi: 10.1016/S0140-6736(11)61484-0. Epub 2011 Oct 24. Lancet. 2011. PMID: 22030144 Clinical Trial.
Cervical pessaries for prevention of preterm birth in women with a multiple pregnancy (ProTWIN): a multicentre, open-label randomised controlled trial.
Liem S, Schuit E, Hegeman M, Bais J, de Boer K, Bloemenkamp K, Brons J, Duvekot H, Bijvank BN, Franssen M, Gaugler I, de Graaf I, Oudijk M, Papatsonis D, Pernet P, Porath M, Scheepers L, Sikkema M, Sporken J, Visser H, van Wijngaarden W, Woiski M, van Pampus M, Mol BW, Bekedam D. Liem S, et al. Lancet. 2013 Oct 19;382(9901):1341-9. doi: 10.1016/S0140-6736(13)61408-7. Epub 2013 Aug 5. Lancet. 2013. PMID: 23924878 Clinical Trial.
Induction of labour or expectant monitoring in hypertensive pregnancy disorders at term: do women's postpartum cardiovascular risk factors differ between the two strategies?
Hermes W, Koopmans CM, van Pampus MG, Franx A, Bloemenkamp KW, van der Post J, Porath M, Tamsma JT, Mol BW, de Groot CJ. Hermes W, et al. Eur J Obstet Gynecol Reprod Biol. 2013 Nov;171(1):30-4. doi: 10.1016/j.ejogrb.2013.08.006. Epub 2013 Aug 11. Eur J Obstet Gynecol Reprod Biol. 2013. PMID: 24011382 Clinical Trial.
Induction of labour at term with oral misoprostol versus a Foley catheter (PROBAAT-II): a multicentre randomised controlled non-inferiority trial.
Ten Eikelder ML, Oude Rengerink K, Jozwiak M, de Leeuw JW, de Graaf IM, van Pampus MG, Holswilder M, Oudijk MA, van Baaren GJ, Pernet PJ, Bax C, van Unnik GA, Martens G, Porath M, van Vliet H, Rijnders RJ, Feitsma AH, Roumen FJ, van Loon AJ, Versendaal H, Weinans MJ, Woiski M, van Beek E, Hermsen B, Mol BW, Bloemenkamp KW. Ten Eikelder ML, et al. Lancet. 2016 Apr 16;387(10028):1619-28. doi: 10.1016/S0140-6736(16)00084-2. Epub 2016 Feb 3. Lancet. 2016. PMID: 26850983 Clinical Trial.
Nifedipine versus atosiban for threatened preterm birth (APOSTEL III): a multicentre, randomised controlled trial.
van Vliet EOG, Nijman TAJ, Schuit E, Heida KY, Opmeer BC, Kok M, Gyselaers W, Porath MM, Woiski M, Bax CJ, Bloemenkamp KWM, Scheepers HCJ, Jacquemyn Y, Beek EV, Duvekot JJ, Franssen MTM, Papatsonis DN, Kok JH, van der Post JAM, Franx A, Mol BW, Oudijk MA. van Vliet EOG, et al. Among authors: porath mm. Lancet. 2016 May 21;387(10033):2117-2124. doi: 10.1016/S0140-6736(16)00548-1. Epub 2016 Mar 2. Lancet. 2016. PMID: 26944026 Clinical Trial.
Temporizing management vs immediate delivery in early-onset severe preeclampsia between 28 and 34 weeks of gestation (TOTEM study): An open-label randomized controlled trial.
Duvekot JJ, Duijnhoven RG, van Horen E, Bax CJ, Bloemenkamp KW, Brussé IA, Dijk PH, Franssen MT, Franx A, Oudijk MA, Porath MM, Scheepers HC, van Wassenaer-Leemhuis AG, van Drongelen J, Mol BW, Ganzevoort W; TOTEM study collaboration group. Duvekot JJ, et al. Among authors: porath mm. Acta Obstet Gynecol Scand. 2021 Jan;100(1):109-118. doi: 10.1111/aogs.13976. Epub 2020 Aug 28. Acta Obstet Gynecol Scand. 2021. PMID: 33319930 Free PMC article. Clinical Trial.
An economic analysis of immediate delivery and expectant monitoring in women with hypertensive disorders of pregnancy, between 34 and 37 weeks of gestation (HYPITAT-II).
van Baaren GJ, Broekhuijsen K, van Pampus MG, Ganzevoort W, Sikkema JM, Woiski MD, Oudijk MA, Bloemenkamp K, Scheepers H, Bremer HA, Rijnders R, van Loon AJ, Perquin D, Sporken J, Papatsonis D, van Huizen ME, Vredevoogd CB, Brons J, Kaplan M, van Kaam AH, Groen H, Porath M, van den Berg PP, Mol B, Franssen M, Langenveld J; HYPITAT-II Study Group. van Baaren GJ, et al. BJOG. 2017 Feb;124(3):453-461. doi: 10.1111/1471-0528.13957. Epub 2016 Mar 10. BJOG. 2017. PMID: 26969198 Clinical Trial.
110 results